Latest News about JNJ
Recent news which mentions JNJ
Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath
March 04, 2025
From Benzinga
Warren Buffett's State of the Market
March 03, 2025
From Motley Fool
These Vanguard ETFs Show Where the Smart Money Is Moving Now
March 03, 2025
From Motley Fool
From Motley Fool
3 Dividend Stocks That Are No-Brainer Buys Right Now
March 01, 2025
From Motley Fool
Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform
February 28, 2025
From Benzinga
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang
February 28, 2025
From Benzinga
Wall Street's Greatest Dividend Stock Just Made History Again -- and 99.9% of Investors Have Never Heard of This Small-Cap Company
February 28, 2025
From Motley Fool
Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says
February 27, 2025
From Benzinga
Johnson & Johnson Sues Samsung Bioepis Over Alleged Biosimilar Agreement Breach For Its Flagship Psoriasis Drug
February 26, 2025
From Benzinga
A Closer Look at Johnson & Johnson's Options Market Dynamics
February 26, 2025
Tickers
JNJ
From Benzinga
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
February 24, 2025
From Motley Fool
From Motley Fool
NVIDIA's New AI System Aims To Transform Genetic Research With Unmatched Speed And Precision
February 20, 2025
From Benzinga
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
February 19, 2025
From Benzinga
Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst
February 18, 2025
From Benzinga
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
February 18, 2025
From Benzinga
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
February 13, 2025
From Benzinga
Congress Member Josh Gottheimer Dumps Nvidia, Microsoft, Loads Up On Tesla Stocks Instead
February 12, 2025
From Benzinga
P/E Ratio Insights for Johnson & Johnson
February 12, 2025
From Benzinga
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
February 12, 2025
From Benzinga
Warren Buffett's Granddaughter Claimed He Cut Her Off And She Couldn't Afford Health Insurance: 'He Disowned My Twin Sister And Myself'
February 09, 2025
Tickers
JNJ
From Benzinga
2 Stocks to Buy if There Is a Market Crash in 2025
February 09, 2025
From Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
February 08, 2025
From Motley Fool
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
February 07, 2025
From Benzinga
Kenvue's Q4 Sales Miss, Margins Improve
February 06, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.